Newsroom

LONDON--(BUSINESS WIRE)--    DMO-TAS041/3753/004         The Minster Building21 Mincing LaneLondonEC3R 7AG T 020 7862 6500F 020 7862 6509www.dmo.gov.uk           A147\26 29 October 2026   PRESS NOTICE   RESULT OF THE SALE BY TENDER OF UP TO £1000 MILLION OF 0¼% TREASURY GILT 2031The United Kingdom Debt Management Office ("DMO") announces that the tender of up to £1,000 million of 0¼% Treasury Gilt 2031 (ISIN Code: GB00BMGR2809) has been allocated as follows:(Note: all prices in this notice are...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - November 28.10.2026 GNOV LN IE000OJ31JQ4  800,002.00 USD  30,518,002.37   38.147  ...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

BENGASI, Libia e KAHRAMANMARAŞ, Turchia--(BUSINESS WIRE)--Alushibe Holding Group ha annunciato oggi l'intenzione di portare 12 marchi internazionali del settore Food & Beverage in Libia entro il 2028 attraverso la sua divisione Retail & Destinations, a partire da un accordo di master franchising esclusivo con MADO, la gelateria e pasticceria turca fondata nel 1850. Firmato a Kahramanmaraş il 13 ottobre 2026 da Ahmed Gadalla, fondatore e presidente di Alushibe Holding Group, e Mehmet Sai...

BENGHAZI, Libye, et KAHRAMANMARAŞ, Türkiye--(BUSINESS WIRE)--Alushibe Holding Group a annoncé aujourd’hui son intention d’introduire 12 enseignes internationales de restauration en Libye d’ici 2028, par l’intermédiaire de sa division Retail & Destinations. Cette initiative débutera par un contrat exclusif de master franchise conclu avec MADO, enseigne turque de glaces et de pâtisseries fondée en 1850. Signé à Kahramanmaraş le 13 octobre 2026 par Ahmed Gadalla, fondateur et président d’Alush...

BENGHAZI, Libië en KAHRAMANMARAŞ, Turkije--(BUSINESS WIRE)--Alushibe Holding Group heeft vandaag plannen aangekondigd om tegen 2028 12 internationale horecamerken naar Libië te brengen via haar divisie Retail & Destinations, te beginnen met een exclusieve master-franchiseovereenkomst met MADO, het Turkse ijs- en banketbakkerijhuis dat in 1850 werd opgericht. De overeenkomst, ondertekend in Kahramanmaraş op 13 oktober 2026 door Ahmed Gadalla, oprichter en voorzitter van Alushibe Holding Grou...

MINNEAPOLIS--(BUSINESS WIRE)--Xcel Energy Inc. (NASDAQ: XEL) today reported 2026 third quarter GAAP earnings of $960 million, or $1.52 per share, compared with $524 million, or $0.88 per share in the same period in 2025 and ongoing earnings of $961 million, or $1.52 per share compared with $737 million or $1.24 per share in the same period in 2025. See Note 6 for reconciliation from GAAP to ongoing earnings. The change in earnings per share was primarily driven by increased recovery of electric...

PARMA, Italy--(BUSINESS WIRE)--Chiesi, the international research-focused biopharmaceutical group, today announced the appointment of Paolo Paoletti, M.D. to its Board of Directors, effective as of today. Paoletti is an internationally recognized pharmaceutical executive with more than 30 years of experience across research and development, corporate leadership and biotechnology innovation. Throughout his career, he has held senior leadership positions at Lilly, GlaxoSmithKline (GSK) and GammaD...

MELBOURNE, Fla.--(BUSINESS WIRE)--L3Harris Technologies (NYSE: LHX) reported its third quarter 2026 results. “Our team’s exceptional execution delivered solid financial performance in the third quarter. We grew backlog to record levels, underscoring the consistently strong demand for our mission-critical capabilities. Our priority now is to convert that demand into results. We will continue to invest in production capacity and differentiated capabilities across missiles and missile solutions, s...